Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report

OBJECTIVE: This retrospective study investigated the efficacy and safety of bevacizumab treatment for refractory brain edema. METHODS: Between March 2009 and December 2015, bevacizumab was used to treat 59 cases of brain metastatic patients with refractory brain edema. The median dose of bevacizumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangying, Zhao, Rugang, Shen, Ge, Dong, Dapeng, Ding, Lijuan, Wu, Shikai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682776/
https://www.ncbi.nlm.nih.gov/pubmed/29095257
http://dx.doi.org/10.1097/MD.0000000000008280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682776/
https://www.ncbi.nlm.nih.gov/pubmed/29095257
http://dx.doi.org/10.1097/MD.0000000000008280

Ejemplares similares